Intuitive Surgical, Inc. $ISRG Stock Position Cut by Evelyn Partners Investment Management LLP

Evelyn Partners Investment Management LLP cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 59.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,772 shares of the medical equipment provider’s stock after selling 44,842 shares during the period. Evelyn Partners Investment Management LLP’s holdings in Intuitive Surgical were worth $16,722,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Tobam raised its position in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the period. TD Capital Management LLC lifted its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares in the last quarter. 1248 Management LLC acquired a new position in shares of Intuitive Surgical in the first quarter worth about $30,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical in the second quarter worth approximately $30,000. Finally, Bank of Jackson Hole Trust raised its holdings in shares of Intuitive Surgical by 70.5% during the first quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 31 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, VP Fredrik Widman sold 2,067 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the completion of the sale, the vice president owned 473 shares in the company, valued at $260,150. The trade was a 81.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 105 shares of the stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $560.00, for a total value of $58,800.00. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 116,164 shares of company stock valued at $61,916,172. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $561.61 on Friday. The stock’s 50 day simple moving average is $492.09 and its 200 day simple moving average is $504.31. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The firm has a market cap of $201.32 billion, a PE ratio of 74.29, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period last year, the company posted $1.84 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. BTIG Research increased their price target on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. HSBC boosted their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Jefferies Financial Group increased their target price on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.